HOUSE DOCKET, NO. 308 FILED ON: 1/13/2015
HOUSE . . . . . . . . . . . . . . . No. 941
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
John W. Scibak
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to the care and treatment of patients with mitochondrial disease.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
John W. Scibak | 2nd Hampshire | 1/13/2015 |
Elizabeth A. Poirier | 14th Bristol | 9/5/2019 |
Angelo J. Puppolo, Jr. | 12th Hampden | 1/20/2015 |
Peter V. Kocot | 1st Hampshire | 9/5/2019 |
Marjorie C. Decker | 25th Middlesex | 9/5/2019 |
Ruth B. Balser | 12th Middlesex | 9/5/2019 |
Tackey Chan | 2nd Norfolk | 9/5/2019 |
Kay Khan | 11th Middlesex | 9/5/2019 |
Louis L. Kafka | 8th Norfolk | 9/5/2019 |
Chris Walsh | 6th Middlesex | 9/5/2019 |
John J. Lawn, Jr. | 10th Middlesex | 9/5/2019 |
Thomas M. Stanley | 9th Middlesex | 9/5/2019 |
Jennifer L. Flanagan | Worcester and Middlesex | 9/5/2019 |
Timothy R. Madden | Barnstable, Dukes and Nantucket | 9/5/2019 |
Tom Sannicandro | 7th Middlesex | 9/5/2019 |
Paul McMurtry | 11th Norfolk | 9/5/2019 |
Denise C. Garlick | 13th Norfolk | 9/5/2019 |
Brian M. Ashe | 2nd Hampden | 9/5/2019 |
Theodore C. Speliotis | 13th Essex | 9/5/2019 |
Michael S. Day | 31st Middlesex | 9/5/2019 |
Antonio F. D. Cabral | 13th Bristol | 9/5/2019 |
Paul Brodeur | 32nd Middlesex | 9/5/2019 |
Garrett J. Bradley | 3rd Plymouth | 2/4/2015 |
HOUSE DOCKET, NO. 308 FILED ON: 1/13/2015
HOUSE . . . . . . . . . . . . . . . No. 941
By Mr. Scibak of South Hadley, a petition (accompanied by bill, House, No. 941) of John W. Scibak and others relative to insurance coverage and payment for prescribed treatment for mitochondrial disease. Financial Services. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Eighty-Ninth General Court
(2015-2016)
_______________
An Act relative to the care and treatment of patients with mitochondrial disease.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 32A of the General Law is hereby amended by inserting after section 17K the following section:-
Section 17L. The commission shall provide to any active or retired employee of the commonwealth or spouse/dependent who is insured under the group insurance commission, coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 2. Chapter 175 of the General Laws is hereby amended by inserting after section 47DD the following section:-
Section 47EE. Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 3. Chapter 176A of the General Laws is hereby amended by inserting after section 8EE the following section:-
Section 8FF. Any contract between a subscriber and a corporation under an individual or group hospital service plan delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 4. Chapter 176B of the General Laws is hereby amended by inserting after section 4FF the following section:-
Section 4GG. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 5. Chapter 176G of the General Laws is hereby amended by inserting after section 4X the following section:-
Section 4Y. Any individual or group health maintenance contract shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.